The development, enhancement, and reversal of the secondary complications of diabetes mellitus
- PMID: 112028
- DOI: 10.1016/s0046-8177(79)80026-x
The development, enhancement, and reversal of the secondary complications of diabetes mellitus
Abstract
Diabetic glomerulopathy continues as a major problem in the management of the patient with diabetes mellitus; however, evidence in man and in animals underlines the fact that good control of diabetes favorably alters the course of this complication. Islet transplantation in the diabetic rat returns plasma glucose and insulin levels to normal. In parallel mesangial matrix thickening, mesangial deposition of immunoglobulin and urinary excretion of albumin markedly improve following islet transplantation. Although amelioration of diabetes affects the course of glomerulopathy, other factors (most notably measures that increase glomerular capillary pressure) enhance the development of the diabetic renal lesions. Following uninephrectomy or clipping of a renal artery, the remaining (in the case of uninephrectomy) or unclipped diabetic kidney develops the morphologic and functional changes of diabetic nephropathy at a rate greater than in kidneys in an intact diabetic rat. The clipped kidney demonstrates diminished diabetic changes, suggesting a protective effect with decreased glomerular capillary pressures. In addition to measures improving the control of diabetes, procedures reducing factors accelerating diabetic complications may improve the prognosis in diabetic glomerulopathy.
Similar articles
-
Studies of diabetic nephropathy in animals and man.Diabetes. 1976;25(2 SUPPL):850-7. Diabetes. 1976. PMID: 823065
-
Diabetic glomerulopathy in the uninephrectomized rat resists amelioration following islet transplantation.Diabetologia. 1982 Oct;23(4):347-53. doi: 10.1007/BF00253743. Diabetologia. 1982. PMID: 6814977
-
Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels.Diabetes. 1997 Jul;46(7):1198-206. doi: 10.2337/diab.46.7.1198. Diabetes. 1997. PMID: 9200656
-
Role of mesangial expansion in the pathogenesis of diabetic nephropathy.J Nephrol. 2001 Nov-Dec;14 Suppl 4:S51-7. J Nephrol. 2001. PMID: 11798146 Review.
-
The case for control in diabetes mellitus.West J Med. 1978 Sep;129(3):193-200. West J Med. 1978. PMID: 360622 Free PMC article. Review.
Cited by
-
Antithrombin III and fibrinogen degradation product (fragment E) in diabetic nephropathy.J Clin Pathol. 1982 Jun;35(6):661-6. doi: 10.1136/jcp.35.6.661. J Clin Pathol. 1982. PMID: 7085916 Free PMC article.
-
Reduced transcapillary escape of albumin during acute blood pressure-lowering in type 1 (insulin-dependent) diabetic patients with nephropathy.Diabetologia. 1985 Nov;28(11):797-801. doi: 10.1007/BF00291067. Diabetologia. 1985. PMID: 4085693
-
Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy.Diabetologia. 1986 Apr;29(4):211-5. doi: 10.1007/BF00454877. Diabetologia. 1986. PMID: 3710012 Clinical Trial.
-
Early functional and morphologic vascular renal consequences of the diabetic state.Diabetologia. 1979 Aug;17(2):71-6. doi: 10.1007/BF01222205. Diabetologia. 1979. PMID: 385406 Review.
-
Functional and morphological renal manifestations in diabetes mellitus.Diabetologia. 1981 Aug;21(2):89-93. doi: 10.1007/BF00251272. Diabetologia. 1981. PMID: 7021290 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources